The metabolic fate of hepatic glucose can be best studied using invasive techniques such as tracer infusions and frequent blood sampling which have been revealed to be impractical in the pediatric age group. The aim of this study was to develop a non-invasive method based on indirect calorimetry and expired 13CO2 monitoring in order to gain insight into the mechanisms leading to impaired glucose tolerance in children and teenagers. As a first step, net glucose oxidation (NGO) and energy expenditure (EE) were measured in 47 subjects (range 7.5–17.3 years) of whom 18 were prepubertal (P1), 11 in early puberty (P2–P3) and 18 in late puberty (P4–P5) after 3-hourly loads of 180 mg/kg of oral maize glucose containing naturally enriched 13C. Isotope analysis allowed to calculate exogenous and endogenous glucose oxidation (EXGO, ENGO) and, hence, to derive TGS and NGS, that is glycogen turnover. NGO and EE decreased significantly with pubertal progression, reflecting higher metabolism at younger ages, whereas EXGO remained constant. TGS did not change significantly whereas NGS showed a significant negative correlation with pubertal progression: this can be explained by the fact that glycogenolysis exceeded glycogen synthesis in this experimental setting. This non-invasive method appears to be a promising tool to study the fate of hepatic glucose and therefore glycogen turnover in children at risk of developing glucose intolerance and/or type 2 diabetes.

Keywords:
Hepatic glucose metabolism, Whole-body glycogen turnover, Puberty, Indirect calorimetry, 13C glucose
1.
Umpleby AH, Sönksen PH: Measurement of the turnover of substrate of carbohydrates and protein metabolism using radioactive isotopes. Baillères Clin Endocr Metab 1987;1:773–796.
2.
Petersen KF, Laurent D, Rothman DL, Cline GW, Shulman GI: Mechanisms by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest 1998;101:1203–1209.
3.
Taylor R, Magnusson I, Rothman DL, Cline DW, Caumo A, Cobelli C, Shulman GI: Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest 1996;97:126–132.
4.
Magnusson I, Rothman DL, Jucker B, Cline GW, Shulman RG, Shulman GI: Liver glycogen turnover in fed and fasted humans. Am J Physiol 1994;266:E796–E803.
5.
Shulman GI, Rothman DL, Chung Y, Rossetti L, Petit WA Jr, Barrett EJ, Shulman RG: 13C NMR studies of glycogen turnover in the perfused rat liver. J Biol Chem 1988;263:5027–5029.
6.
Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J: Role of suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 1992;326:22–29.
7.
Turk D, Alzaid A, Dinneen S, Nair KS, Rizza R: The effects on non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest 1995;95:755–762.
8.
Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S: Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802–810.
9.
Tappy L, Paquot N, Tounian P, Schneiter P, Jéquier E: Assessment of glucose metabolism in humans with the simultaneous use of indirect calorimetry and tracer techniques. Clin Physiol 1995;15:1–12.
10.
Lefebvre PJ: Naturally labeled 13C-glucose: A new tool to measure oxidation rate of exogenous glucose. Diabetes 1979;28(suppl 1):63–65.
11.
Gay LJ, Schneiter P, Schutz Y, Di Vetta V, Jéquier E, Tappy L: A non-invasive assessment of hepatic glycogen kinetics and post-absorptive gluconeogenesis in man. Diabetologia 1994;27:517–523.
12.
Reilly JJ: Assessment of body composition in infants and children. Nutrition 1998;14:821–825.
13.
Deurenberg P, Pieters JJL, Hautvast JGA: The assessment of the body fat percentage by skinfold thickness measurements in childhood and young adolescence. Br J Nutr 1990;63:293–303.
14.
Tanner JM: Growth at Adolescence. Oxford, Blackwell Scientific, 1962.
15.
Burr IA, Sizonenko PC, Kaplan SL, Grumbach MM: Hormonal changes in puberty. I. Correlation of serum luteinizing hormone and follicle-stimulating hormone with stages of puberty, testicular size and bone age in normal boys. Pediatr Res 1970;4:25–35.
16.
Sizonenko PC, Burr IA, Kaplan SL, Grumbach MM: Hormonal changes in puberty. II. Correlation of serum-luteinizing hormone and follicle-stimulating hormone with stages of puberty and bone age in normal girls. Pediatr Res 1970;4:36–40.
17.
Haycock GB, Schwartz GJ, Wisotsky DH: Geometric method for measuring body surface area: A height-weight formula validated in infants, children, and adults. J Pediatr 1978;93:62–66.
18.
Selz R, Theintz G, Tappy L, Schneiter P: Evaluation of hepatic and whole body glycogen metabolism in humans during repeated administration of small loads of 13C glucose. Diabetes Metab 2003;29:643–649.
19.
Battilana P, Ornstein K, Minehira K, Schwarz JM, Achesonn K, Schneiter P, Burri J, Jéquier E, Tappy L: Mechanisms of action of β-glucan in postprandial glucose metabolism in healthy men. Eur J Clin Nutr 2001;55:327–333.
20.
Livesey G, Elia M: Estimation of energy expenditure, net carbohydrate utilization, and net fat oxidation and synthesis by indirect calorimetry: Evaluation of errors with special reference to the detailed composition of fuels. Am J Clin Nutr 1988;47:608–628.
21.
Ferrannini E: The theoretical basis of indirect calorimetry. A review. Metabolism 1988;37:287–301.
22.
Tappy L, Schneiter P: Measurement of substrate oxidation in man. Diabetes Metab 1997;23:435–442.
23.
Robert JJ, Koziet J, Chauvet D, Darmaun D, Desjeux JF, Young VR: Use of 13C-labeled glucose for estimating glucose oxidation: Some design considerations. J Appl Physiol 1987;63:1725–1732.
24.
Hoerr RA, Yu YM, Wagner DA, Burke JF, Young VR: Recovery of 13C in breath from NaH13CO3 infused by gut and vein: Effect of feeding. Am J Physiol 1989;257:E426–E438.
25.
Leijssen DP, Elia M: Recovery of 13CO2 and 14CO2 in human bicarbonate studies: A critical review with original data. Clin Sci 1996;91:665–677.
26.
Tounian P, Schneiter P, Henry S, Tappy L: Effects of infused glucose on glycogen metabolism in healthy humans. Clin Physiol 1996;16:403–416.
27.
Hargreaves M: Skeletal muscle metabolism during exercise in humans. Clin Exp Pharmacol Physiol 2000;27:225–228.
28.
Jéquier E: Carbohydrate as a source of energy. Am J Clin Nutr 1994;59(suppl):682–685.
29.
Le Stunff C, Bougnères PF: Time course of increased lipid and decreased glucose oxidation during early phase of childhood obesity. Diabetes 1993;42:1010–1016.
30.
Mosora F, Lefebvre P, Pirnay F, Lacroix M, Luyckx A, Duchesne J: Quantitative evaluation of the oxidation of an exogenous glucose load using naturally labeled 13C-glucose. Metabolism 1976;25:1575–1582.
31.
Cowett RM, Wolfe RR: Glucose and lactate kinetics in the neonate. J Dev Physiol 1991;16:341–347.
32.
Sunehag AL, Treuth MS, Toffolo G, Butte NF, Cobelli C, Bier DM, Haymond MW: Glucose production, gluconeogenesis, and insulin sensitivity in children and adolescents: An evaluation of their reproducibility. Pediatr Res 2001;50:115–123.
33.
Weinsier RL, Schutz Y, Bracco D: Reexamination of the relationship of resting metabolic rate to fat-free mass and to the metabolically active components of fat-free mass in humans. Am J Clin Nutr 1992;55:790–794.
34.
Peronnet F, Adopo E, Massicotte D, Brisson G, Hillaire-Marcel C: Comparison of two methods for computing exogenous substrate oxidation using 13C-labelling. Med Sci Sports Exerc 1993;25:297–302.
35.
Molnar D, Schutz Y: The effect of obesity, age, puberty and gender on resting metabolic rate in children and adolescents. Eur J Pediatr 1997;156:376–381.
36.
Holliday MA: Metabolic rate and organ size during growth from infancy to maturity and during late gestation and early infancy. Pediatrics 1947;47:169–179.
37.
Bitar A, Fellmann N, Vernet J, Coudert J, Vermorel M: Variations and determinants of energy expenditure as measured by whole-body indirect calorimetry during puberty and adolescence. Am J Clin Nutr 1999;69:1209–1216.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.